Physician profile
Gregory S Laffitte
NPI 1841261336
$1,177.84
in general payments reported to CMS, 2019-2025
14 companies · $98.06 in 2025
The $98.06 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $51.86 · 2022: $287 · 2023: $380 · 2024: $361 · 2025: $98.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $806 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $806.39 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $363.19 | 2021-2024 | Wegovy, Saxenda |
| Lilly USA, LLC | $241.49 | 2023-2024 | Mounjaro, Zepbound |
| Abbott Laboratories | $216.94 | 2021-2025 | Freestyle Libre 3 |
| Alexion Pharmaceuticals, INC. | $77.89 | 2023-2025 | Strensiq |
| Novartis Pharmaceuticals Corporation | $45.73 | 2024 | |
| Tolmar, INC. | $39.09 | 2023-2024 | |
| Xeris Pharmaceuticals, INC. | $33.34 | 2022-2024 | Recorlev |
| Amgen INC. | $30.89 | 2024-2025 | Evenity |
| Tolmar Pharmaceuticals, INC. | $28.84 | 2022 | |
| Azurity Pharmaceuticals, INC. | $24.15 | 2024 | Triptodur |
| Bayer Healthcare Pharmaceuticals INC. | $20.78 | 2022 | |
| Radius Health, INC. | $20.31 | 2022 | |
| Nevro Corp. | $18.38 | 2024 | Senza |
| Kowa Pharmaceuticals America, INC. | $16.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Laffitte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.